THE MANAGEMENT OF TREATMENT-RESISTANT SCHIZOPHRENIA

被引:4
作者
BREIER, A
机构
关键词
D O I
10.1097/00001504-199501000-00010
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
Several important developments in the pharmacotherapy of treatment-resistant schizophrenia have occurred over the past year. These developments include the resolution of questions related to the clinical application and safety of clozapine, the widespread introduction of risperidone, and new approaches to the treatment of negative symptoms and cognitive impairment. These developments will be critically examined and future challenges for the management of treatment-resistant schizophrenia will be discussed.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 25 条
[1]
ALPHS LD, 1989, PSYCHOPHARMACOL BULL, V25, P149
[2]
CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].
ALVIR, JMJ ;
LIEBERMAN, JA ;
SAFFERMAN, AZ ;
SCHWIMMER, JL ;
SCHAAF, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167
[3]
BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891
[4]
BREIER A, 1993, HOSP COMMUNITY PSYCH, V44, P1145
[5]
BREIER A, 1994, AM J PSYCHIAT, V151, P20
[6]
CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25
[7]
RISPERIDONE VERSUS HALOPERIDOL IN THE TREATMENT OF CHRONIC-SCHIZOPHRENIC INPATIENTS - A MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY [J].
CLAUS, A ;
BOLLEN, J ;
DECUYPER, H ;
ENEMAN, M ;
MALFROID, M ;
PEUSKENS, J ;
HEYLEN, S .
ACTA PSYCHIATRICA SCANDINAVICA, 1992, 85 (04) :295-305
[8]
RITANSERIN, A SELECTIVE 5-HT(2/1C) ANTAGONIST, AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - A PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL [J].
DUINKERKE, SJ ;
BOTTER, PA ;
JANSEN, AAI ;
VANDONGEN, PAM ;
VANHAAFTEN, AJ ;
BOOM, AJ ;
VANLAARHOVEN, JHM ;
BUSARD, HLSM .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :451-455
[9]
THE EFFECT OF CLOZAPINE ON COGNITION AND PSYCHIATRIC-SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA [J].
GOLDBERG, TE ;
GREENBERG, RD ;
GRIFFIN, SJ ;
GOLD, JM ;
KLEINMAN, JE ;
PICKAR, D ;
SCHULZ, SC ;
WEINBERGER, DR .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 :43-48
[10]
IMPROVEMENT IN COGNITIVE FUNCTIONS AND PSYCHIATRIC-SYMPTOMS IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS RECEIVING CLOZAPINE [J].
HAGGER, C ;
BUCKLEY, P ;
KENNY, JT ;
FRIEDMAN, L ;
UBOGY, D ;
MELTZER, HY .
BIOLOGICAL PSYCHIATRY, 1993, 34 (10) :702-712